Abstract
The successful development of cisplatin in clinical use inspired research on metallic complexes as therapeutic agents for cancer diseases. Among them, N-heterocyclic carbenes (NHCs), which serve as a privileged scaffold, can stabilize a variety of transition metals through covalent metal-NHC bonds. These particular characteristics enabled metal-NHC complexes to be developed as clinical drug candidates. Studies demonstrated that metal-NHC complexes exhibited excellent anticancer bioactivities, which encouraged inorganic medicinal chemists to discover and develop novel metal-NHC complexes for cancer treatment. This chapter summarizes the anticancer bioactivities and mechanisms of platinum, rhodium, gold, and silver NHC complexes and provides novel therapeutic strategies for cancer treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
